ORIC Pharmaceuticals Inc’s recently made public that its PRESIDENT AND CEO Chacko Jacob unloaded Company’s shares for reported $0.65 million on Mar 06 ’24. In the deal valued at $16.21 per share,40,000 shares were sold. As a result of this transaction, Chacko Jacob now holds 728,544 shares worth roughly $7.83 million.
Then, Chacko Jacob sold 26,042 shares, generating $320,186 in total proceeds. Upon selling the shares at $12.29, the PRESIDENT AND CEO now owns 768,544 shares.
Before that, Chacko Jacob sold 13,958 shares. ORIC Pharmaceuticals Inc shares valued at $169,160 were divested by the PRESIDENT AND CEO at a price of $12.12 per share. As a result of the transaction, Chacko Jacob now holds 794,586 shares, worth roughly $8.54 million.
Cantor Fitzgerald initiated its ORIC Pharmaceuticals Inc [ORIC] rating to an Overweight in a research note published recently. A number of analysts have revised their coverage, including Wedbush’s analysts, who began to cover the stock in late September with a ‘”an Outperform”‘ rating. H.C. Wainwright also remained covering ORIC and has increased its forecast on March 23, 2023 with a “Buy” recommendation from previously “Neutral” rating. Guggenheim revised its rating on March 21, 2023. It rated ORIC as “a Buy” which previously was an “a Neutral”.
Price Performance Review of ORIC
On Monday, ORIC Pharmaceuticals Inc [NASDAQ:ORIC] saw its stock fall -2.01% to $10.75. Over the last five days, the stock has lost -16.86%. ORIC Pharmaceuticals Inc shares have risen nearly 16.85% since the year began. Nevertheless, the stocks have risen 99.81% over the past one year. While a 52-week high of $16.65 was reached on 03/06/24, a 52-week low of $4.89 was recorded on 01/08/24. SMA at 50 days reached $12.75, while 200 days put it at $9.09. A total of 0.5 million shares were traded, compared to the trading of 0.63 million shares in the previous session.
Levels Of Support And Resistance For ORIC Stock
The 24-hour chart illustrates a support level at 10.45, which if violated will result in even more drops to 10.15. On the upside, there is a resistance level at 11.06. A further resistance level may holdings at 11.37. The Relative Strength Index (RSI) on the 14-day chart is 30.19, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.94, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 94.07%. Stochastics %K at 3.05% indicates the stock is a buying.
How much short interest is there in ORIC Pharmaceuticals Inc?
A steep rise in short interest was recorded in ORIC Pharmaceuticals Inc stocks on Mar 15, 2024, growing by 0.39 million shares to a total of 6.93 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 6.54 million shares. There was a rise of 5.63%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 11.17% of the overall stock float, the days-to-cover ratio (short ratio) rose to 9.4.
